Delivery Order SPE2DB24D3013-SPE2DB25FFNRT
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,137.38 for Trulicity 1.5 mg/0.5 ml pen injectors on August 21, 2025, with completion scheduled for August 22, 2025. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $27,548.20 for the supply of Trulicity 3 mg/0.5 ml pen injectors on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and Department of Defense...
- The Defense Logistics Agency (DLA) awarded a $1,248.04 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on August 5, 2025, with a completion date of August 6, 2025. This firm fixed-price contract was competitively awarded without a set-aside designation and is being performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,041.04 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 30, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $4,413.01 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 11, 2025, with completion scheduled for August 12, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within the pharmaceutical distribution portfolio that AmerisourceBergen...
- The Defense Logistics Agency awarded a $12,054.36 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,504.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pen injectors on July 22, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,582.57 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on July 14, 2025, with completion expected by July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran...
- The Defense Logistics Agency (DLA) awarded a $2,279.93 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pen injectors on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its Corporate Office location in Conshohocken, PA. Trulicity is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNRTDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,801.80 for Trulicity 1.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 25, 2025. This is a firm fixed price, non-set-aside delivery order issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Trulicity is a diabetes medication widely used in military and federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has demonstrated capability to fulfill federal medical procurement requirements through its existing portfolio of delivery orders covering a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains. The SPE2DX IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with critical medical commodities to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/24/25 |